900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
Product containing precisely carboplatin 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carvedilol 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carvedilol 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carvedilol 3.125 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carvedilol 6.25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefalexin 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefalexin 250 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefalexin 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefazolin (as cefazolin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefixime 20 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefixime 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefixime 400 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefotaxime (as cefotaxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ceftazidime 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ceftazidime 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ceftriaxone (as ceftriaxone sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ceftriaxone (as ceftriaxone sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cefuroxime (as cefuroxime sodium) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely certolizumab pegol 200 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chlorambucil 2 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chloramphenicol (as chloramphenicol palmitate) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chloramphenicol 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chlorhexidine (as chlorhexidine gluconate) 40 milligram/1 gram conventional release cutaneous gel (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chlorhexidine gluconate 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chloroquine phosphate 16 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chloroquine phosphate 160 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chloroquine phosphate 250 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chloroquine sulfate 13.6 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chloroquine sulfate 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chloroxylenol 48 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chlorpromazine hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chlorpromazine hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chlorpromazine hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely chlorpromazine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ciclosporin 25 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 2 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ciprofloxacin 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cisplatin 1 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clarithromycin 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clarithromycin 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clarithromycin 500 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clofazimine 100 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clofazimine 50 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clomifene citrate 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clomipramine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clomipramine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clopidogrel (as clopidogrel besilate) 75 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clopidogrel (as clopidogrel bisulfate) 300 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clopidogrel (as clopidogrel hydrochloride) 75 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release vaginal cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clotrimazole 100 milligram/1 gram conventional release vaginal cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clotrimazole 500 milligram/1 each conventional release vaginal tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cloxacillin (as cloxacillin sodium) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cloxacillin (as cloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cloxacillin (as cloxacillin sodium) 500 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cloxacillin (as cloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clozapine 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clozapine 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clozapine 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely clozapine 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely coagulation factor IX 1000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely coagulation factor IX 500 unit/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely coagulation factor VIII 500 unit/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely coal tar 50 milligram/1 gram conventional release cutaneous emulsion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely codeine phosphate 30 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely colecalciferol 10 microgram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely colecalciferol 10 microgram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely colecalciferol 25 microgram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely colistimethate sodium 1 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cyclizine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cyclizine lactate 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cyclophosphamide 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cyclophosphamide 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cyclophosphamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cycloserine 125 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cycloserine 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cytarabine 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cytarabine 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 110 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 150 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely dacarbazine (as dacarbazine citrate) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)

Start Previous Page 406 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)